GlaxoSmithKline LLC and SmithKline Beecham (Cork) Limited v. Teva Pharmaceuticals USA, Inc.

In a closely watched patent case that is especially important to pharmaceutical patent litigation, a divided panel of the Federal Circuit upheld a verdict against Teva Pharmaceuticals USA, Inc. for $235 million for inducing infringement of a method patent. The panel upheld the inducement finding even though Teva had used a special “carve-out” procedure to omit any reference to the patented method or the condition it is used to treat. In this rehearing petition, Goodwin attorneys urge the full Federal Circuit to rehear the case. Seven amicus briefs have been filed supporting the petition.

GlaxoSmithKline LLC and SmithKline Beecham (Cork) Limited v. Teva Pharmaceuticals USA, Inc.

Amicus Briefs

Apotex Amicus Brief

R Street Amicus Brief

AAM Amicus Brief

Fifty-seven Professors Amicus Brief

Novartis-Sandoz Amicus Brief

Mylan Amicus Brief

Waxman Amicus Brief

 

Download PDF